Experimental infusion phlebitis: tolerance pH of peripheral vein
- PMID: 10349613
- DOI: 10.2131/jts.24.113
Experimental infusion phlebitis: tolerance pH of peripheral vein
Abstract
This study aims to determine the pH that peripheral veins can tolerate. Intravenous nutrient solutions with different pHs (from 4.52 to 6.71) were infused into rabbit ear veins, and the veins were examined histopathologically. After 6-hr infusion at 10 mL/kg/hr, a commercial 2.72% amino acid/7.5% glucose solution with electrolytes (AG) caused obvious phlebitic changes, such as loss of venous endothelial cells, inflammatory cell infiltration, and perivascular edema, in all 6 rabbits because of its low pH (4.52) and high titratable acidity (22 mEq/L). The phlebitis was reduced when the solution was neutralized with NaOH to pH 5.93, and was almost eliminated when the pH was neutralized to 6.49. After 8-hr infusion at 15 mL/kg/hr, AG-adjusted pH to 6.30 caused slight phlebitic changes, but AG-adjusted pH to 6.71 scarcely caused any change. Furthermore, 24-hr infusion of the pH 6.49 solution caused no histopathological changes in 3 rabbits. These results suggest that the tolerance pH for the peripheral vein is about 6.5, and that an infusion solution does not cause phlebitis due to acidity if the pH is not lower than the tolerance pH.
Similar articles
-
Effects of pH and osmolality on phlebitic potential of infusion solutions for peripheral parenteral nutrition.J Toxicol Sci. 1998 Feb;23(1):77-85. doi: 10.2131/jts.23.77. J Toxicol Sci. 1998. PMID: 9513923
-
Experimental infusion phlebitis: importance of titratable acidity on phlebitic potential of infusion solution.Clin Nutr. 1996 Jun;15(3):129-32. doi: 10.1016/s0261-5614(96)80037-9. Clin Nutr. 1996. PMID: 16844015
-
Experimental infusion phlebitis: tolerance osmolality of peripheral venous endothelial cells.Nutrition. 1998 Jun;14(6):496-501. doi: 10.1016/s0899-9007(98)00037-9. Nutrition. 1998. PMID: 9646289
-
Vinorelbine and venous irritation: optimal parenteral administration.J Oncol Pharm Pract. 2005 Jun;11(2):79-81. doi: 10.1191/1078155205jp146oa. J Oncol Pharm Pract. 2005. PMID: 16460608 Review.
-
Treatment of infusion-related phlebitis: review and nursing protocol.J Intraven Nurs. 1993 Sep-Oct;16(5):282-6. J Intraven Nurs. 1993. PMID: 8229430 Review.
Cited by
-
Administration of chemotherapy via the median cubital vein without implantable central venous access ports: port-free chemotherapy for metastatic colorectal cancer patients.Int J Clin Oncol. 2015 Apr;20(2):332-7. doi: 10.1007/s10147-014-0703-5. Epub 2014 May 10. Int J Clin Oncol. 2015. PMID: 24811333
-
Managing hyperglycemia during the COVID-19 pandemic: Improving outcomes using new technologies in intensive care.SAGE Open Med. 2020 Nov 19;8:2050312120974174. doi: 10.1177/2050312120974174. eCollection 2020. SAGE Open Med. 2020. PMID: 33282306 Free PMC article. Review.
-
Emergency medicine: magnesium sulphate injections and their pharmaceutical quality concerns.Heliyon. 2021 May 22;7(5):e07099. doi: 10.1016/j.heliyon.2021.e07099. eCollection 2021 May. Heliyon. 2021. PMID: 34095588 Free PMC article.
-
Effects of lipid emulsion and multivitamins on the growth of microorganisms in peripheral parenteral nutrition solutions.Int J Med Sci. 2013 Jun 26;10(9):1079-84. doi: 10.7150/ijms.6407. Print 2013. Int J Med Sci. 2013. PMID: 23869182 Free PMC article.
-
A Case of Metronidazole Injection Infiltration Without Sequelae.Hosp Pharm. 2017 Sep;52(8):559-563. doi: 10.1177/0018578717722885. Epub 2017 Aug 4. Hosp Pharm. 2017. PMID: 29276289 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources